Capsular Polysaccharides as Human Vaccines (Q40108352)

17 September 2017

1 reference

title

Capsular polysaccharides as human vaccines (English)

1 reference

17 September 2017

Capsular Polysaccharides as Human Vaccines (English)

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

26 August 2023

1 reference

H. J. Jennings

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6195893

26 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6195893

26 August 2023

publication date

1 January 1983

1 reference

Advances in Carbohydrate Chemistry and Biochemistry

17 September 2017

published in

1 reference

17 September 2017

volume

41

1 reference

17 September 2017

page(s)

155-208

1 reference

THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY : III. A QUANTITATIVE STUDY AND A THEORY OF THE REACTION MECHANISM.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

A "pure" organic chemists downward path

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Emergence of Antibiotic Resistance In Hospitals, 1935-1975

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Epidemiology of Klebsiella and Hospital-Associated Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Artificial Salmonella vaccines: Salmonella typhimurium O-antigen-specific oligosaccharide-protein conjugates elicit opsonizing antibodies that enhance phagocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The syntactic bases for French liaison

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

PREPARATION OF THE TYPE-SPECIFIC POLYSACCHARIDE OF THE TYPE I MENINGOCOCCUS AND A STUDY OF ITS EFFECTIVENESS AS AN ANTIGEN IN HUMAN BEINGS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Characterization of 3-deoxy-D-manno-octulosonic acid as a component of the capsular polysaccharide antigen from Neisseria meningitidis serogroup 29-e

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural elucidation of the 3-deoxy-D-manno-octulosonic acid containing meningococcal 29-e capsular polysaccharide antigen using carbon-13 nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structures of the Capsular Polysaccharides of Neisseria meningitidis as Determined by 13C-Nuclear Magnetic Resonance Spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural determination of the polysaccharide antigens of Neisseria meningitidis serogroups Y, W-135, and BO1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Polysaccharide structures using carbon-13 nuclear magnetic resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Isolation of 9-O-(α-d-N-acetylneuraminyl)-β-d-N- acetylneuraminic acid by partial acid hydrolysis, and its characterisation by 13C n.m.r

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structure of the 3-deoxy-D-manno-octulosonic acid-containing polysaccharide (K6 antigen) from Escherichia coli LP 1092

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of two capsular polysaccharides elaborated by different strains of Haemophilus influenzae type e

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the Haemophilus influenzae type e capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the capsular polysaccharide elaborated by Haemophilus influenza type d

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural and immunological studies of the Haemophilus influenzae type d capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The structure of the capsular antigen from Haemophilus influenzae type a

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the capsular antigen of haemophilus infuenzae type c

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the capsular antigen from Haemophilus influenzae type f

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the Haemophilus influenzae type f capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

A serological differentiation of human and other groups of hemolytic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCES.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Type-specific polysaccharide antigens of group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Existence of multiple immunodeterminants in the type-specific capsular substance of group B type Ia streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Isolation of type-specific polysaccharide antigen from group B type Ib streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Immunodeterminant specificity of human immunity to type III group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural determination and serology of the native polysaccharide antigen of type-III group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Type-specific polysaccharide antigens of group B streptococci. II. The chemical basis for serological specificity of the type II HCl antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Immunochemical characterization of the "native" type III polysaccharide of group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structure and serology of the native polysaccharide antigen of type Ia group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies on the specific type-14 pneumococcal polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The Pneumococcal Polysaccharides: A Re-Examination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Some biological properties of Pneumococcus type 37 and the chemistry of its capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The structure of capsular polysaccharide of the pneumococcus type II

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The specific capsular polysaccharide of Streptococcus pneumoniae type 9V

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the capsular antigen from streptococcus pneumoniae type 26

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The type-specific substance from Pneumococcus type 11A(43).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The type-specific substance from Pneumococcus type 13.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The specific capsular polysaccharide of Streptococcus pneumoniae type 15F

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The type-specific substance from Pneumococcus type 29.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The specific substance from Pneumococcus type 34 (41). The phosphodiester linkages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies of the capsular polysaccharide from Streptococcus pneumoniae type 4

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

[12] Methylation analysis of polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : XII. THE IMMUNOLOGICAL PROPERTIES OF AN ARTIFICIAL ANTIGEN CONTAINING CELLOBIURONIC ACID.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

SPECIFIC FRACTIONATION OF HUMAN ANTI-DEXTRAN ANTIBODIES. 3. FRACTIONATION OF ANTI-DEXTRAN BY SEQUENTIAL EXTRACTION WITH OLIGOSACCHRIDES OF INCREASING CHAIN LENGTH AND ATTEMPTS AT SUBFRACTIONATION

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structure and immunochemistry of the cell wall mannans from Saccharomyces chevalieri, Saccharomyces italicus, Saccharomyces diastaticus, and Saccharomyces carlsbergensis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Conformational aspects critical to the immunospecificity of the type III group B streptococcal polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Shapely polysaccharides. The eighth Colworth Medal Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Order-disorder transition for a bacterial polysaccharide in solution. A role for polysaccharide conformation in recognition between Xanthomonas pathogen and its plant host

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Conformation of crystalline type III pneumococcal polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Pneumococcal polysaccharide conformations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Characterization of group C meningococcal polysaccharide by light-scattering spectroscopy. III. Determination of molecular weight, radius of gyration, and translational diffusional coefficient

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The effect of variation in molecular weight on the antigenicity of dextran in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Sialic Acid-Containing Polysaccharides of Neisseria meningitidis and Escherichia coli Strain Bos-12: Structure and Immunology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The R-type lipopolysaccharides of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Polysaccharide capsule of Escherichia coli: microscope study of its size, structure, and sites of synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Electron microscopic studies on streptococci. I. M antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Electron Microscopic Definition of Surface Antigens of Group B Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The Chemistry and Biosynthesis of Selected Bacterial Capsular Polymers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

T and B Lymphocytes and Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Phagocyte strategy vs. microbial tactics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The role of complement in the host's defense against Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Activation of the alternative complement pathway by Haemophilus influenzae type B

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Activation of the alternative complement pathway by a streptococcal lipoteichoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The role of the physical state of lipopolysaccharides in the interaction with complement. High molecular weight as prerequisite for the expression of anti-complementary activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Isolation and partial characterization of a polysaccharide in ant venom (Pseudomyrmex sp.) that activates the classical complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Maturation of Regulatory Factors Influencing Magnitude of Antibody Response to Capsular Polysaccharide of Type III Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Formation of Antibody in the Newborn Mouse: Study of T-Cell-Independent Antibody Response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Studies on immunological paralysis. VI. Thymic-independence of tolerance and immunity to type 3 pneumococcal polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Evidence for thymus-independent humoral antibody production in mice against polyvinylpyrrolidone and E. coli lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Genetic control of the immune response. The effect of thymectomy on the primary and secondary antibody response of mice to poly-L(tyr, glu)-poly-D, L-ala--poly-L-lys

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The human antibody response to simultaneous injection of six specific polysaccharides of pneumococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The prevalence of pneumococcal types and the continuing importance of pneumococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Immune Response of Human Infants to Polysaccharide Vaccines of Groups A and C Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Immunologic response of man to group B meningococcal polysaccharide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Identification of a subgroup antigen on the Neisseria meningitidis group C capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Comparative Immunogenicity of Vaccines Prepared from Capsular Polysaccharides of Group C Neisseria meningitidis O.Acetyl.Positive and O.Acetyl.Negative Variants and Escherichia coli K92 in Adult Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Structural studies on the sialic acid polysaccharide antigen of Escherichia coli strain Bos-12

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Interim Report of a Controlled Field Trial of Immunization with Capsular Polysaccharides of Haemophilus influenzae Type band Group C Neisseria meningitidis in Mecklenburg County, North Carolina (March 1974-March 1976)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Immunization of Humans with Polyribophosphate, the Capsular Antigen of Hemophilus influenzae, Type b

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Demonstration of opsonic activity and in vivo protection against group B streptococci type III by Streptococcus pneumoniae type 14 antisera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : IV. THE SYNTHESIS OF THEp-AMINOBENZYL ETHER OF THE SOLUBLE SPECIFIC SUBSTANCE OF TYPE III PNEUMOCOCCUS AND ITS COUPLING WITH PROTEIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

STUDIES ON ANTIBACTERIAL IMMUNITY INDUCED BY ARTIFICIAL ANTIGENS : II. IMMUNITY TO EXPERIMENTAL PNEUMOCOCCAL INFECTION WITH ANTIGENS CONTAINING SACCHARIDES OF SYNTHETIC ORIGIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

STUDIES ON ANTIBACTERIAL IMMUNITY INDUCED BY ARTIFICIAL ANTIGENS : I. IMMUNITY TO EXPERIMENTAL PNEUMOCOCCAL INFECTION WITH AN ANTIGEN CONTAINING CELLOBIURONIC ACID

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

PRODUCTION OF ANTIBODIES TO DENATURED DEOXYRIBONUCLEIC ACID (DNA)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Neoglycoproteins: the preparation and application of synthetic glycoproteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Coupling of acid labile salmonella specific oligosaccharides to macromolecular carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Excursions into Epidemiology: Selected Studies during the Past Four Decades at Boston City Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Some contributions of immunochemistry to biochemistry and biology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The specific capsular polysaccharide of type VII Pneumococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Immunochemical relationships between bacteria belonging to two separate families: Pneumococci and Klebsiella

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Immunogenicity of group A and group C meningococcal polysaccharides in human infants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Induction of SerumHaemophilus influenzaeType B Capsular Antibodies in Adult Volunteers Fed Cross-ReactingEscherichia coli075:K100:H5

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

THE PROTECTIVE ACTION OF A SPECIFIC ENZYME AGAINST TYPE III PNEUMOCOCCUS INFECTION IN MICE.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Molecular cloning of the K1 capsular polysaccharide genes of E. coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

An autosomal dominant gene regulates the extent of 9-O-acetylation of murine erythrocyte sialic acids. A probable explanation for the variation in capacity to activate the human alternate complement pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2318%2808%2960058-X

7 January 2021

Mass-spectral studies of isometric d-ribofuranosylribitol disaccharides from the capsular polysaccharides of Haemophilus influenzae type b and Escherichia coli K 100

54

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic

26 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Journal of Biological Chemistry

26 August 2023

71

author name string

Jennings

publication date

1980

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Journal of the Chemical Society

26 August 2023

128

469

Rees

1971

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Molecular Biology and Chemistry of the Alternative Pathway of Complement

26 August 2023

152

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Studies in Human Subjects of Polyvalent Pneumococcal Vaccines

26 August 2023

180

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Artificial Salmonella Vaccines: Salmonella typhimurium O-Antigen-Specific Oligosaccharide-Protein Conjugates Elicit Protective Antibodies in Rabbits and Mice

26 August 2023

211

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Journal of Biological Chemistry

26 August 2023

223

author name string

Egan

publication date

1972

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis

26 August 2023

226

1 reference

https://api.crossref.org/works/10.1016/S0065-2318(08)60058-X

26 August 2023

Identifiers

0 references

1 reference